ODDB.org: Open Drug Database

Swissmedic Registration	63182	Date of registration	26.08.2014
Company name	Bristol-Myers Squibb SA	Revision date
		Valid until
Indication		Date of market entry
Index Therapeuticus (BSV)	07.16.10.	Revocation Date
Index Therapeuticus (Swissmedic)	07.16.10.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Abraxane 100 mg	Pulver zur Herstellung einer Infusionsdispersion	Pulver zur Herstellung einer Infusionsdispersion (Paclitaxel 100 mg)	L01CD01
02	Abraxane 250 mg	Pulver zur Herstellung einer Infusionssuspension	Pulver zur Herstellung einer Infusionssuspension (Paclitaxel 5 mg)	Codice

2025	©ywesee GmbH